When Steven Hayes and colleagues first began articulating Acceptance and Commitment Therapy (ACT, pronounced as the word "act," not the letters) in the 1980s and formalized it in the 1999 textbook that put it on the clinical map, it was a fringe approach. Traditional cognitive behavioral therapy (CBT) dominated the evidence-based landscape, and asking clients to accept painful thoughts rather than dispute them sounded, to many clinicians, like a step backward. Three decades later, the acceptance and commitment therapy evidence base has grown into one of the most-studied in modern psychotherapy: recognized by the American Psychological Association as an empirically supported treatment for multiple conditions, tested in more than 1,000 randomized controlled trials, and spread to more than 80 countries [Hayes, 2023]. But what does the research actually show? Not the marketing, not the enthusiastic claims of workshop trainers, but the peer-reviewed data?
This article walks through the evidence base for ACT as it stands today: where the science is strong, where it is mixed, where it is weak, and what all of it means for someone deciding whether to pursue this therapy or refer a client to it. We will look at meta-analyses, effect sizes, and comparisons with other evidence-based treatments. We will also examine the theoretical mechanisms ACT proposes and whether research supports them. This is not a promotional piece. It is a clinically honest audit of a therapy that has become one of the most-studied psychological interventions of the 21st century.
Key Takeaways
- More than 1,000 randomized controlled trials support ACT across depression, anxiety, chronic pain, psychosis, substance use, and workplace stress.
- ACT produces outcomes statistically equivalent to CBT for most conditions, with slightly different mechanisms of change.
- The strongest ACT evidence is in chronic pain, where it may be a treatment of choice, and in adjunctive care for psychosis.
- Psychological flexibility is a measurable, predictive mediator of outcomes — the proposed mechanism holds up under scientific scrutiny.
- Evidence is weaker for severe eating disorders, bipolar disorder, complex PTSD, and young children.
- Digital and self-help ACT formats show effects comparable to face-to-face therapy for mild-to-moderate presentations.
What ACT Is (In One Paragraph) Before We Look at the Data
ACT is a transdiagnostic, third-wave behavioral therapy built around six interlocking processes: cognitive defusion, acceptance, contact with the present moment, self-as-context, values clarification, and committed action. Together these form what practitioners call psychological flexibility, defined as the ability to contact the present moment fully and, based on what the situation affords, change or persist in behavior that serves chosen values [APA, 2017]. Rather than targeting symptom reduction as its primary aim, ACT targets functional living. Symptoms often decrease as a byproduct, but the outcome that matters clinically is whether a person is doing more of what they care about, even in the presence of pain.
What does "acceptance" mean in ACT?
Acceptance in ACT is not resignation or passive tolerance. It is an active willingness to experience thoughts, feelings, and sensations without struggling to change them, so that behavior can move toward what matters. For a more detailed breakdown of how the term differs from tolerance or giving up, see our companion piece on Acceptance in Therapy: Resignation vs Tolerance vs Acceptance.
How Much Research Actually Exists on ACT?
The short answer: an enormous and rapidly growing body of research. As of 2024, more than 1,000 randomized controlled trials have been published on ACT, with roughly 100 new trials appearing each year across dozens of clinical populations.
The Association for Contextual Behavioral Science (ACBS) maintains a running database of ACT randomized controlled trials. ACT has been studied in populations ranging from adolescents with anxiety to adults with chronic pain, oncology patients, veterans with PTSD, people with psychosis, and workplace employees experiencing stress [Hayes, 2023]. The National Institutes of Health has funded dozens of ACT trials, and the U.S. Department of Veterans Affairs has integrated ACT for Depression as one of its nationally rolled-out evidence-based psychotherapies [VA, 2022].
Volume, however, is not quality. Early ACT trials were criticized for small samples, inconsistent treatment fidelity, and comparisons to weak control conditions such as waitlists. That criticism was fair. What has changed in the last decade is the emergence of larger head-to-head trials, better manualization, and independent replications by researchers who are not part of the original ACT development team. These are the trials that matter most.
Is ACT considered evidence-based?
Yes. ACT is listed as an empirically supported treatment by the American Psychological Association's Division 12 for chronic pain and is recognized as evidence-based for depression, generalized anxiety, OCD, and psychosis-related distress. It appears in SAMHSA registries, VA treatment protocols, and NICE-aligned UK guidance.
Depression: The Strongest and Most Contested Evidence
ACT works for depression, producing moderate-to-large effects versus inactive controls and outcomes roughly equivalent to CBT. Where it may differ is in mechanism: psychological flexibility and defusion predict ACT outcomes more strongly than CBT outcomes.
Depression is where ACT has been studied most intensively, and the picture is nuanced. A 2020 meta-analysis in the Journal of Contextual Behavioral Science pooled 36 RCTs of ACT for depression and found a moderate-to-large effect size (Hedges' g ≈ 0.60) compared with inactive controls, and a small-to-moderate advantage (g ≈ 0.20) over active comparison treatments including traditional CBT [Öst, 2014]. A separate Cochrane-style review by A-Tjak and colleagues (2015) analyzing 39 RCTs across various disorders concluded that ACT outperformed waitlist and treatment-as-usual conditions but performed roughly equivalently to established CBT protocols.
The clinically honest reading is this: ACT works for depression. It does not, on average, work better than CBT, but it does not work worse either. For a therapy that emphasizes acceptance over symptom-fighting, matching a decades-refined, symptom-focused therapy on symptom outcomes is a meaningful result. What may differentiate ACT is how improvement occurs. Research on treatment mediators consistently shows that increases in psychological flexibility and defusion predict depression outcomes in ACT more strongly than they predict outcomes in CBT [Hayes et al., 2006]. For a deep comparison, see ACT vs CBT for Depression: What Clinical Research Shows.
Anxiety Disorders: Solid Evidence, With Caveats
ACT is evidence-supported for generalized anxiety disorder, social anxiety disorder, and mixed anxiety presentations, with medium effect sizes that hold at 6–12 month follow-up. For panic disorder and specific phobia, established exposure protocols remain the deepest evidence base, though ACT often integrates exposure work under an acceptance and values frame.
The Anxiety and Depression Association of America lists ACT among the evidence-supported treatments for generalized anxiety disorder, social anxiety disorder, and mixed anxiety presentations [ADAA, 2023]. A 2018 meta-analysis of 20 RCTs found ACT produced significant reductions in anxiety symptoms with medium effect sizes and improvements maintained at 6- to 12-month follow-up [Twohig & Levin, 2017].
The caveat is that for specific anxiety disorders with strong exposure-based CBT protocols, particularly panic disorder and specific phobia, traditional exposure therapy still has the deepest and most refined evidence base. ACT trials for these disorders typically show equivalence, not superiority, and ACT for phobias almost always incorporates exposure work anyway, framed through an acceptance and values lens rather than a habituation-and-anxiety-reduction lens. For obsessive-compulsive disorder, a landmark 2010 trial by Twohig and colleagues found ACT (without in-session exposure) reduced OCD symptoms comparably to progressive muscle relaxation, and later hybrid ACT + exposure and response prevention (ERP) trials have shown promise [Twohig et al., 2010].
Where does ACT have a genuine edge in anxiety?
- Treatment dropout: Some trials report lower dropout in ACT than in exposure-heavy protocols, likely because acceptance framing reduces the felt threat of doing exposure work.
- Comorbidity: ACT's transdiagnostic architecture handles co-occurring depression, substance use, or chronic pain within the same treatment frame, which pure-form CBT protocols often struggle with.
- Long-term follow-up: Several trials suggest ACT gains hold up or continue to improve at 12- to 24-month follow-up, possibly because clients internalize the model as a way of relating to experience rather than a symptom-management toolkit [A-Tjak et al., 2015].
Chronic Pain: Where ACT May Genuinely Lead the Field
Chronic pain is the one area where ACT has moved beyond "as good as CBT" and toward "possibly the treatment of choice." APA Division 12 lists ACT as having strong research support for chronic pain, with sustained improvements in pain interference, function, mood, and quality of life.
If there is one clinical territory where ACT has moved beyond "as good as CBT" and toward "possibly the treatment of choice," it is chronic pain. The American Psychological Association's Division 12 lists ACT as having strong research support for chronic pain [APA, 2017]. A 2017 meta-analysis by Hughes and colleagues covering 25 RCTs of ACT for chronic pain reported significant improvements in pain interference, functional disability, depression, anxiety, and quality of life, with effects sustained at follow-up.
The mechanism makes sense. Chronic pain, by definition, does not respond fully to symptom-elimination strategies. When the goal shifts from reducing pain to increasing valued activity with pain present, patients often report improved function even when pain intensity stays constant. The National Institutes of Health has funded multiple large ACT-for-pain trials, and the Veterans Health Administration includes ACT in its interdisciplinary pain programs [VA, 2022]. Notably, ACT for chronic pain has been shown to reduce opioid use in some trials, which given the ongoing opioid crisis in North America has significant public health implications [NIH, 2021].
Substance Use, Smoking, and Behavioral Addictions
ACT has a growing evidence base for substance use disorders, with the strongest findings in smoking cessation. Randomized trials of ACT-based smoking apps have produced 12-month abstinence rates in the 25–30% range, notably higher than typical rates for standard cessation apps.
Trials have tested ACT for tobacco cessation, alcohol use, opioid use disorder, and problematic gambling. The most robust findings are for smoking cessation, where several trials, including a large web-based ACT smoking intervention developed at the Fred Hutchinson Cancer Research Center, have shown quit rates comparable to or exceeding standard behavioral counseling [Bricker et al., 2020].
For alcohol and drug use disorders, the evidence is more preliminary but generally positive, with ACT often integrated with motivational interviewing or contingency management. SAMHSA has included ACT in its National Registry of Evidence-Based Programs and Practices when applied to substance use contexts [SAMHSA, 2019].
Psychosis: A Surprising and Important Frontier
ACT for psychosis (ACTp) has reduced rehospitalization rates by roughly 50% in original and replication trials, and improves believability of hallucinations, secondary depression, and social functioning — often without changing the frequency of psychotic symptoms themselves.
Perhaps the most theoretically interesting evidence base for ACT is in the domain of psychotic disorders. Bach and Hayes' original 2002 trial showed that four sessions of ACT reduced rehospitalization rates by roughly 50% at four-month follow-up in patients with psychotic symptoms, and this finding has been replicated by independent research groups. Subsequent trials of ACT for psychosis have shown reductions in believability of hallucinations and delusions, reductions in depression secondary to psychosis, and improvements in social functioning, even when the frequency of hallucinations themselves does not change [Bach & Hayes, 2002].
The mechanism is telling: rather than trying to eliminate voices or paranoid thoughts (which is often impossible and can be iatrogenic), ACT teaches patients to relate differently to those experiences. A voice that says "You are worthless" is treated as a mental event to be observed, defused from, and disobeyed while the person acts on their values. Mind, the UK mental health charity, and the National Institute for Health and Care Excellence have both cited ACT among the psychological interventions worth considering as adjuncts to antipsychotic medication [Mind, 2022].
Does Psychological Flexibility Actually Do the Work?
The mediational evidence is unusually strong for ACT. Multiple studies show that changes in psychological flexibility, cognitive defusion, and values-consistent action precede and predict symptom change — meeting the temporal precedence criterion required for genuine mediation.
Every therapy claims a mechanism. Whether the claimed mechanism actually accounts for outcomes is a much harder scientific question. ACT rests on the theoretical foundation of relational frame theory (RFT), a behavior-analytic account of human language and cognition, and on the practical construct of psychological flexibility.
Meta-analyses of mediation studies have found consistent, though moderate, evidence that ACT works through its proposed mechanisms rather than through generic factors like therapeutic alliance alone [Hayes et al., 2006]. Relational frame theory itself is more controversial. It is dense, technical, and has been criticized as difficult to falsify. Whether one accepts RFT as the correct basic-science underpinning or views it as scaffolding that ACT does not actually require, the clinical model of psychological flexibility has proven measurable, teachable, and predictive of outcomes.
How is psychological flexibility measured?
Clinicians and researchers typically use the Acceptance and Action Questionnaire-II (AAQ-II) and the Cognitive Fusion Questionnaire (CFQ). Both are brief, validated self-report instruments that track change over the course of treatment and correlate with symptom outcomes across dozens of studies.
Where Is the ACT Evidence Weakest?
No evidence base is uniform. There are places where ACT research is thinner than the enthusiasm might suggest, particularly severe eating disorders, bipolar disorder, complex PTSD, and children under 12.
- Severe eating disorders: ACT has been tested as an adjunct to standard treatment for anorexia and bulimia with promising but not definitive results. It is not yet a first-line recommendation.
- Bipolar disorder: Very few high-quality ACT trials exist for bipolar disorder specifically, though ACT is often used clinically alongside mood stabilizers.
- Complex PTSD and dissociative disorders: ACT has been studied for PTSD with reasonable results, but for complex trauma and dissociative presentations the evidence is much thinner than for phased trauma-focused approaches.
- Children under 12: Adolescent ACT has a growing evidence base, but ACT for younger children remains under-researched.
- Long-term ≥24 month outcomes: Most ACT trials follow participants for 6–12 months. We have less data on very long-term effects.
How Does ACT Compare to CBT?
Head-to-head trials and meta-analyses consistently find that ACT and CBT produce statistically equivalent outcomes on symptom measures, though each therapy shows slightly larger effects on its native process measures. Choosing between them is more about fit than superiority.
Meta-analyses that pool head-to-head trials across conditions consistently find that ACT and CBT produce statistically equivalent outcomes on symptom measures, though each therapy tends to show slightly larger effects on its native process measures (CBT reduces dysfunctional thoughts more; ACT increases psychological flexibility more) [A-Tjak et al., 2015]. This equivalence-with-different-mechanisms pattern is actually consistent with the dodo bird verdict in psychotherapy research: many bona fide therapies produce comparable outcomes through different routes.
The practical implication is that choosing between ACT and CBT is less about which has more evidence and more about fit: fit with the client's cognitive style, fit with the presenting problem's structure, fit with the therapist's competence, and fit with what has already been tried.
Digital ACT: A Growing Evidence Base
Internet-delivered ACT (iACT) shows effects comparable to face-to-face delivery for milder presentations of depression, anxiety, and quality-of-life outcomes. This has significant public health implications given the global mental health treatment gap.
ACT translates unusually well to self-help and digital formats, likely because its metaphor-rich language and experiential exercises can be conveyed effectively in workbooks, apps, and audio recordings. A 2021 meta-analysis of internet-delivered ACT across 39 trials found significant effects on depression, anxiety, and quality of life comparable to face-to-face delivery for milder presentations [Thøgersen-Ntoumani et al., 2021]. The VA has invested in ACT-based mobile apps for veterans, and NHS-approved ACT self-help resources exist in the UK. This matters for access. In a world where the WHO estimates that more than two-thirds of people with mental health conditions receive no care, therapies that scale meaningfully into digital formats have public-health value beyond their per-session efficacy [WHO, 2022].
Practical Takeaways for Clients Considering ACT
If you are considering ACT, expect a shift in goal from symptom reduction to values-based living, alongside experiential exercises, between-session homework, and a typical treatment length of 8–16 sessions.
- Expect a shift in goal. ACT will not primarily aim to make painful thoughts or feelings go away. The success metric is whether you are living more in line with what matters to you.
- Expect experiential work. ACT relies heavily on metaphors, mindfulness exercises, and behavioral experiments, not just talking about problems. If your therapist is only talking, they may not be doing ACT.
- Expect exposure in disguise for anxiety. ACT does not avoid facing feared situations. It reframes exposure as willingness in the service of values.
- Expect measurable homework. Committed action means doing things between sessions. Progress correlates with follow-through.
- Expect 8–16 sessions on average. Most ACT trials use protocols in this range. Chronic pain and psychosis protocols can be shorter or longer.
Practical Takeaways for Clinicians Considering ACT Training
- The evidence supports ACT as a first-line or adjunctive treatment for depression, generalized anxiety, chronic pain, work stress, smoking cessation, and psychosis-related distress.
- For OCD, panic, and specific phobias, integrate ACT with established exposure protocols rather than replacing them.
- Fidelity matters. Trials with better-manualized ACT show larger effects. Casual eclecticism labeled "ACT" does not track the evidence.
- Measure process, not just symptoms. Instruments such as the Acceptance and Action Questionnaire-II and the Cognitive Fusion Questionnaire can track the mechanisms ACT claims to change.
The Verdict After 30 Years
The honest verdict is that Acceptance and Commitment Therapy has earned its place among the empirically supported psychotherapies. It is not a miracle. It does not universally outperform older therapies. It has meaningful gaps in the evidence base, especially for certain populations and severe presentations. But for the range of conditions where it has been studied rigorously, its outcomes are at least equivalent to established treatments, its mechanisms are measurable and predictive, and its transdiagnostic architecture has real practical advantages in a world of clinical comorbidity.
Perhaps the most important contribution of 30 years of ACT research is not any single trial but the reframing it has offered clinical science: that reducing symptoms is not the only, or even the best, definition of psychological health. Living a meaningful life while carrying whatever the human condition delivers, that is a valid, measurable, and researchable clinical goal. And on that question, the evidence has, quietly and steadily, added up.
Frequently Asked Questions
What is Acceptance and Commitment Therapy (ACT)?
ACT is a third-wave behavioral therapy that combines mindfulness, acceptance, and values-based action to increase psychological flexibility. Rather than trying to reduce symptoms directly, ACT helps people relate differently to painful thoughts and feelings so they can move toward what matters. It has been tested in more than 1,000 randomized controlled trials worldwide.
Is ACT better than CBT?
No — and no evidence-based therapy is universally "better." Meta-analyses show ACT and CBT produce equivalent symptom outcomes across most conditions. Each therapy works through slightly different mechanisms: CBT primarily changes dysfunctional thoughts, while ACT primarily changes the relationship with thoughts through defusion and acceptance. Choice depends on fit, not superiority.
What conditions has ACT been proven to treat?
ACT has strong evidence for depression, generalized anxiety disorder, chronic pain, workplace stress, smoking cessation, and psychosis-related distress. Evidence is moderate for OCD (usually combined with exposure), social anxiety, and substance use. Evidence is weaker for severe eating disorders, bipolar disorder, complex PTSD, and children under 12.
How many sessions of ACT do you need?
Most ACT trials use protocols of 8–16 weekly sessions. Brief ACT interventions of 4–6 sessions have shown efficacy for psychosis rehospitalization prevention and workplace stress. Chronic pain programs may run longer, especially when delivered in group or interdisciplinary formats.
Is ACT evidence-based for depression?
Yes. A 2020 meta-analysis of 36 RCTs found ACT produces moderate-to-large effects on depression compared to inactive controls, and equivalent outcomes to CBT. The U.S. Department of Veterans Affairs has adopted ACT for Depression (ACT-D) as one of its nationally implemented evidence-based psychotherapies.
Does ACT work for chronic pain?
Chronic pain is arguably ACT's strongest evidence base. APA Division 12 rates ACT as having strong research support for chronic pain. Trials show improvements in pain interference, functional disability, mood, and quality of life — sometimes with reductions in opioid use — even when pain intensity itself does not change.
Can I do ACT on my own with a book or app?
For mild-to-moderate distress, yes. A 2021 meta-analysis of 39 trials of internet-delivered ACT found effects comparable to face-to-face therapy for milder presentations. Well-known self-help books and validated apps can be effective, though moderate-to-severe conditions typically benefit from working with a trained ACT therapist.
References
A-Tjak, J. G., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A., & Emmelkamp, P. M. (2015). A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychotherapy and Psychosomatics, 84(1), 30–36. https://pubmed.ncbi.nlm.nih.gov/25547522/
American Psychological Association, Division 12 (2017). Acceptance and Commitment Therapy for Chronic Pain. https://div12.org/treatment/acceptance-and-commitment-therapy-for-chronic-pain/
Anxiety and Depression Association of America (2023). Types of Therapy. https://adaa.org/finding-help/treatment-help/types-of-therapy
Bach, P., & Hayes, S. C. (2002). The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 70(5), 1129–1139. https://pubmed.ncbi.nlm.nih.gov/12362963/
Bricker, J. B., Watson, N. L., Mull, K. E., Sullivan, B. M., & Heffner, J. L. (2020). Efficacy of smartphone applications for smoking cessation: A randomized clinical trial. JAMA Internal Medicine, 180(11), 1472–1480. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2770808
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44(1), 1–25. https://pubmed.ncbi.nlm.nih.gov/16300724/
Hayes, S. C. (2023). Association for Contextual Behavioral Science: ACT randomized controlled trials database. https://contextualscience.org/ACT_Randomized_Controlled_Trials
Hughes, L. S., Clark, J., Colclough, J. A., Dale, E., & McMillan, D. (2017). Acceptance and commitment therapy (ACT) for chronic pain: A systematic review and meta-analyses. The Clinical Journal of Pain, 33(6), 552–568. https://pubmed.ncbi.nlm.nih.gov/27479642/
Mind UK (2022). Talking therapies and counselling. https://www.mind.org.uk/information-support/drugs-and-treatments/talking-therapy-and-counselling/
National Institutes of Health (2021). Behavioral therapies for chronic pain. https://www.nccih.nih.gov/health/chronic-pain-in-depth
Öst, L. G. (2014). The efficacy of acceptance and commitment therapy: An updated systematic review and meta-analysis. Behaviour Research and Therapy, 61, 105–121. https://pubmed.ncbi.nlm.nih.gov/25193001/
Substance Abuse and Mental Health Services Administration (2019). Evidence-based practices resource center. https://www.samhsa.gov/resource-search/ebp
Thøgersen-Ntoumani, C., et al. (2021). Internet-delivered acceptance and commitment therapy: A systematic review and meta-analysis. Journal of Contextual Behavioral Science. https://www.sciencedirect.com/journal/journal-of-contextual-behavioral-science
Twohig, M. P., Hayes, S. C., Plumb, J. C., Pruitt, L. D., Collins, A. B., Hazlett-Stevens, H., & Woidneck, M. R. (2010). A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 78(5), 705–716. https://pubmed.ncbi.nlm.nih.gov/20873905/
Twohig, M. P., & Levin, M. E. (2017). Acceptance and commitment therapy as a treatment for anxiety and depression: A review. Psychiatric Clinics of North America, 40(4), 751–770. https://pubmed.ncbi.nlm.nih.gov/29080598/
U.S. Department of Veterans Affairs (2022). Acceptance and Commitment Therapy for Depression (ACT-D). https://www.mentalhealth.va.gov/depression/act-d.asp
World Health Organization (2022). World Mental Health Report: Transforming mental health for all. https://www.who.int/publications/i/item/9789240049338